Table 2 Cardiovascular-risk profile of included participants

BMI

10(16, 17, 19–23, 32, 34)

1902

RE

11.15

–

8.87 to 13.43

98%, p < 0.0001

9.59,p < 0.0001

Age

11(15, 17–23, 32, 34)

2004

FE

1.00

–

0.35 to 1.82

23%,p = 0.003

3.00, p = 0.0031

Platelet count

9(15–17, 19–24)

974

FE

-1.22

-2.42 to -1.65

41.93%,p = 0.09

-1.98,p = 0.047

Blood Pressure

SBP

4(18, 20, 22, 34)

1007

RE

10.08

–

-0.22 to 20.37

97%, p < 0.0001

1.92, p = 0.06

DBP

3(18, 20, 22, 34)

1007

RE

4.60

–

-1.29 to 10.48

97%,p < 0.0001

4.60, p = 0.13

Glucose metabolism

6(17–20, 22, 34)

1297

FE

4.05

–

2.92 to 5.19

90%,p < 0.0001

7.00,p < 0.00001

Lipid metabolism

Total cholesterol

7(16–22, 34)

1629

RE

–

0.19

0.00 to 0.38

68%,p = 0.005

2.00,p = 0.05

HDL Cholesterol

7(16–22, 34)

1629

RE

–

-0.68

-1.25 to -0.12

96%,p < 0.001

2.37,p = 0.02

LDL Cholesterol

7(16–22, 34)

1629

RE

–

0.20

0.00 to 0.41

71%,p = 0.002

2.00,p = 0.05

Triglycerides

7(16–22, 34)

1629

RE

–

0.60

0.20 to 1.01

93%,p < 0.001

2.90,p = 0.004